April 24, 2014 8:00 a.m. to 6:00 p.m.: Neurological Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

Where:

Holiday Inn
Main Ballroom
2 Montgomery Village Ave.
Gaithersburg, MD 20879
301-948-8900

At this meeting, the Neurological Devices Panel of the Medical Devices Advisory Committee will discuss the current knowledge about the safety and effectiveness of aversive conditioning devices that are intended to deliver a noxious electrical stimulus to a patient to modify undesirable behavioral characteristics. FDA is convening this meeting to seek clinical and scientific expert opinion on the risks and benefits of certain aversive conditioning devices based on available scientific data and information. The Agency is considering whether to ban aversive conditioning devices that are intended to administer a noxious electrical stimulus to a patient to modify undesirable behavioral characteristics. The meeting will concern only devices classified under 21 CFR 882.5235 (aversive conditioning device, class II) that are not self-administered.

Please click HERE for the current roster of the Neurological Devices Panel of the Medical Devices Advisory Committee

ISS has over a decade of experience in developing regulatory strategies including support for FDA Advisory Committee meetings. We are involved in more FDA AdComms per year than even the largest pharmaceutical companies. For more information on how ISS can help you prepare for your next meeting, contact info@innovativescience.net.

Do you want to find out what happens during this drug’s FDA AdComm meeting? Great news – ISS can help you! Click on the link below in order to receive a summary of this meeting’s outcome!